MSMichael Scholz

Michael Scholz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Scholz has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Commonly experienced acute and cumulative 8-hour sleep loss differentially affect simulated driving during a night-time to early-morning commute: a randomized controlled crossover trial

    by Stefan Lakämper, Michael Scholz, Thomas Kraemer, Hans-Peter Landolt, Kristina Keller

    Sleep loss is a major contributor to traffic accidents, yet the differential effects of two common real-world patterns of sleep loss, acute total sleep deprivation and cumulative sleep restriction producing an equivalent 8-h sleep loss, on vehicle control remain poorly quantified. Leveraging tightly controlled sleep manipulation and highly immersive driving simulation, we directly compared the effects of different patterns of sleep loss under naturalistic driving conditions. Twenty healthy male participants completed a randomized within-subject crossover sleep design, comprising normal sleep, cumulative sleep restriction (four nights 2 h reduced sleep per night), and acute total sleep deprivation (one night without sleep), each followed by a simulated nighttime-to–early-morning commute. Acute total sleep deprivation produced pronounced impairments in vehicle control. Most prominently, lateral control deteriorated within 4–6 min under acute deprivation, with impairments comparable to those reported at high blood alcohol concentrations (1.2–1.4 g/L). Steering instability and integrated driving performance showed convergent deterioration. In contrast, cumulative sleep restriction resulted in smaller and less consistent changes, while vigilance task performance and speed variability were comparatively preserved across all conditions. Despite graded increases in subjective sleepiness across conditions, cumulative sleep restriction produced only limited changes in driving performance, whereas acute sleep deprivation produced a disproportionate risk to driving safety by selectively and rapidly degrading operational vehicle control. These findings, obtained under ecologically relevant sleep and driving conditions, underscore functional and potentially physiological differences between acute and cumulative sleep loss and, practically, highlight the importance of distinguishing between them when considering sleep-loss–related driving impairment and safety risk. Clinical Trials–name, URL, and registration: Clinical Trial name: Study of Identification of Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety—ClinicalTrials.gov Identifier NCT05585515, released on 18.10.2022, https://clinicaltrials.gov/study/NCT05585515; Swiss National Clinical Trial Portal SNCTP000005089, registered on 12.08.2022, https://www.humanforschung-schweiz.ch/de/studiensuche/studien-detail/58930. IRB Statement: This study was approved by the local ethics committee (Kantonale Ethikkommission Zürich, reference number 2022–01273). No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request. We confirm all methods were performed in accordance with the Declaration of Helsinki and its later amendments.


  • Open Access

    Leveraging the Metabolic Fingerprint of Sleep Deprivation and Sleep Restriction for Forensic Applications: A Machine Learning Study in Oral Fluid Metabolomics

    by Michael Scholz, Andrea E. Steuer, Akos Dobay, Hans-Peter Landolt, Thomas Kraemer

    As sleep loss leads to accidents and impaired safety, a direct metabolic marker would be beneficial for forensic interpretation. In a sufficiently powered, randomized, controlled, crossover trial under realistic conditions, we examined the salivary metabolome of 20 young men (habitual sleep duration 7–9 h) following three interventions: one night of total sleep deprivation, four consecutive nights of sleep restriction to 6 h, and control (8 h of sleep). Oral fluid specimens were repeatedly collected and analyzed using liquid chromatography coupled to mass spectrometry. Logistic regression models were trained to classify unseen samples without reference samples from the same individual. Acute sleep deprivation exhibited a unique metabolic fingerprint that could be detected precisely (F0.5 = 0.90) when using only 12 molecular features. This fingerprint was more pronounced in samples collected in the morning/midday hours. Nevertheless, at all time points, the overall correct predictions by far outweighed the incorrect ones. Four nights of sleep restriction did not lead to exploitable metabolic changes. This study presents a metabolic fingerprint of acute sleep deprivation in oral fluid under realistic conditions and explores practical implications and limitations of its machine learning-aided classification. Metabolomics-based, reference-free sleep loss detection holds potential for applications in forensic, clinical, and occupational contexts.


  • Open Access

    Effects of Sleep Restriction and Sleep Deprivation on Behaviorally Relevant Electrophysiological Signal Patterns Revealed by Interpretable Machine Learning

    by Benjamin Stucky, Michael Scholz, Stefan Lakämper, Kristina Keller, Thomas Kraemer, Hans-Peter Landolt

    Acute and accumulated sleep loss differently impair alertness and cognition, yet context-aware biomarkers remain elusive. We applied interpretable machine learning to multimodal physiological data collected under controlled conditions to identify reliable biomarkers. In a within-participant, cross-over design, 47 healthy men (mean age: 23.7 ± 2.8 years) underwent 5-min waking electroencephalographic (EEG) recordings with eyes open after normal sleep (8 h sleep opportunity), sleep restriction (four nights, 6 h sleep opportunity), and acute total sleep deprivation (0 h sleep opportunity). Recordings included six EEG derivations, and simultaneous heart rate and eye-movement data. A subsample (n = 20) completed subjective sleepiness assessments, psychomotor vigilance tests, and a 22-min immersive driving simulation with EEG monitoring.,Classification models using participant-stratified cross-validation achieved 75% accuracy in distinguishing normal sleep from total deprivation despite varied timepoints and cognitive loads. Key EEG features included frontal theta, alpha and beta power, fronto-central mutual information, and a novel biomarker, frontal Hilbert envelope root mean square of successive differences, indicative of altered cortical excitability. Consistent with differential cognitive impairments, sleep restriction showed a distinct physiological signature compared to control and sleep deprivation, particularly in eye movements and heart rate variability. Importantly, the top-10 features showed subjective and behavioral relevance, explaining up to 37% of the variance in subjective sleepiness, vigilant attention and driving performance.,In conclusion, findings demonstrate the feasibility of interpretable machine learning for identifying electrophysiology-based biomarkers of sleep-related cognitive impairment and underscore the need for diverse samples and tasks to enhance generalizability.


  • Open Access

    Assessing the influence of sleep and sampling time on metabolites in oral fluid: implications for metabolomics studies

    by Michael Scholz, Andrea Eva Steuer, Akos Dobay, Hans-Peter Landolt, Thomas Kraemer

    Introduction: The human salivary metabolome is a rich source of information for metabolomics studies. Among other influences, individual differences in sleep-wake history and time of day may affect the metabolome. Objectives: We aimed to characterize the influence of a single night of sleep deprivation compared to sufficient sleep on the metabolites present in oral fluid and to assess the implications of sampling time points for the design of metabolomics studies. Methods: Oral fluid specimens of 13 healthy young males were obtained in Salivette® devices at regular intervals in both a control condition (repeated 8-hour sleep) and a sleep deprivation condition (total sleep deprivation of 8 h, recovery sleep of 8 h) and their metabolic contents compared in a semi-targeted metabolomics approach. Results: Analysis of variance results showed factor ‘time’ (i.e., sampling time point) representing the major influencer (median 9.24%, range 3.02–42.91%), surpassing the intervention of sleep deprivation (median 1.81%, range 0.19–12.46%). In addition, we found about 10% of all metabolic features to have significantly changed in at least one time point after a night of sleep deprivation when compared to 8 h of sleep. Conclusion: The majority of significant alterations in metabolites’ abundances were found when sampled in the morning hours, which can lead to subsequent misinterpretations of experimental effects in metabolomics studies. Beyond applying a within-subject design with identical sample collection times, we highly recommend monitoring participants’ sleep-wake schedules prior to and during experiments, even if the study focus is not sleep-related (e.g., via actigraphy).


  • Open Access

    Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety (ME-SMART): a monocentric, controlled, randomized, crossover trial

    by Michael Scholz, Stefan Lakaemper, Kristina Keller, Akos Dobay, Andrea Eva Steuer, Hans-Peter Landolt, Thomas Kraemer

    Background: Too little sleep and the consequences thereof are a heavy burden in modern societies. In contrast to alcohol or illicit drug use, there are no quick roadside or workplace tests for objective biomarkers for sleepiness. We hypothesize that changes in physiological functions (such as sleep–wake regulation) are reflected in changes of endogenous metabolism and should therefore be detectable as a change in metabolic profiles. This study will allow for creating a reliable and objective panel of candidate biomarkers being indicative for sleepiness and its behavioral outcomes. Methods: This is a monocentric, controlled, randomized, crossover, clinical study to detect potential biomarkers. Each of the anticipated 24 participants will be allocated in randomized order to each of the three study arms (control, sleep restriction, and sleep deprivation). These only differ in the amount of hours slept per night. In the control condition, participants will adhere to a 16/8 h wake/sleep regime. In both sleep restriction and sleep deprivation conditions, participants will accumulate a total sleep deficit of 8 h, achieved by different wake/sleep regimes that simulate real-life scenarios. The primary outcome is changes in the metabolic profile (i.e., metabolome) in oral fluid. Secondary outcome measures will include driving performance, psychomotor vigilance test, d2 Test of Attention, visual attention test, subjective (situational) sleepiness, electroencephalographic changes, behavioral markers of sleepiness, changes in metabolite concentrations in exhaled breath and finger sweat, and correlation of metabolic changes among biological matrices. Discussion: This is the first trial of its kind that investigates complete metabolic profiles combined with performance monitoring in humans over a multi-day period involving different sleep–wake schedules. Hereby, we aim to establish a candidate biomarker panel being indicative for sleepiness and its behavioral outcomes. To date, there are no robust and easily accessible biomarkers for the detection of sleepiness, even though the vast damage on society is well known. Thus, our findings will be of high value for many related disciplines. Trial registration: ClinicalTrials.gov Identifier NCT05585515, released on 18.10.2022; Swiss National Clinical Trial Portal SNCTP000005089, registered on 12 August 2022.